FDA's Ambitious Regulation of Social Media

FDA regulates advertising and promotion material as labeling. The legal definition of labeling covers just about anything that explicitly or implicitly conveys a message intended to affect a person’s behavior and decision outcomes. How FDA applies its legal tenants of false and misleading information or variations on that theme requires continual updating by FDA and constant re-evaluation by industry. 

Why Should You Attend:

The vehicle for communication has evolved dramatically over the past 100 years and continues to evolve at a rate faster than one can anticipate at times. Through this webinar, participants will learn how to navigate FDA’s interpretations and expectations about a firm’s marketing practices through social media. Applying a new guidance and related guidance documents becomes a new test of the FDA’s legal boundaries and enforcement options.

Who Will Benefit:

Sales and marketing executives and managers

Regulatory managers

In-house legal counsel and contract specialists

Third party consultants

Owners and executive managers of new or developing firms of new or developing firms

Instructor Profile:

Casper Uldriks, through his firm Encore Insight LLC, brings over 32 years of experience with the FDA. He specialized in FDA’s medical device program as a field investigator, served as a senior manager in the Office of Compliance and an associate center director for the Center for Devices and Radiological Health.

Note:

Use coupon code 232082 and get 10% off on registration.

For Registration:

http://www.complianceonline.com/fda-ambitious-regulation-of-social-media-webinar-training-703853-prdw?channel=sciencedz